Personal tools

Coexpression cluster:C1549

From FANTOM5_SSTAR

Revision as of 14:57, 26 November 2012 by Autoedit (talk | contribs)
Jump to: navigation, search


Full id: C1549_breast_liver_Sebocyte_Hepatocyte_pancreas_Bronchial_Prostate



Phase1 CAGE Peaks

Hg19::chr9:139379041..139379050,-p@chr9:139379041..139379050
-
Hg19::chr9:139379054..139379061,-p@chr9:139379054..139379061
-
Hg19::chr9:139379069..139379135,-p@chr9:139379069..139379135
-
Hg19::chr9:139379145..139379159,-p@chr9:139379145..139379159
-
Hg19::chr9:139379164..139379180,-p@chr9:139379164..139379180
-
Hg19::chr9:139379206..139379215,-p@chr9:139379206..139379215
-


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


No results for this coexpression

Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data


No GOStat results

Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br>disease_data<br>


Uber Anatomy
Ontology termp-valuen
endoderm-derived structure8.10e-33160
endoderm8.10e-33160
presumptive endoderm8.10e-33160
digestive system1.88e-26145
digestive tract1.88e-26145
primitive gut1.88e-26145
endo-epithelium4.21e-2382
respiratory system4.99e-2174
subdivision of digestive tract1.73e-19118
foregut5.00e-1987
respiratory tract1.68e-1654
gut epithelium8.72e-1454
gland3.13e-1259
exocrine gland6.97e-1231
exocrine system6.97e-1231
respiratory primordium8.16e-1238
endoderm of foregut8.16e-1238
segment of respiratory tract1.20e-1147
organ system subdivision1.04e-10223
trunk region element8.37e-10101
mucosa8.70e-1020
primordium1.20e-09160
immaterial anatomical entity1.20e-09117
epithelial bud3.30e-0937
transitional epithelium4.93e-096
multi-tissue structure7.87e-09342
epithelium of foregut-midgut junction1.22e-0825
anatomical boundary1.22e-0825
hepatobiliary system1.22e-0825
foregut-midgut junction1.22e-0825
septum transversum1.22e-0825
organism subdivision2.36e-08264
urothelium2.55e-085
epithelial fold3.66e-0847
subdivision of trunk4.82e-08112
thoracic cavity element6.40e-0834
thoracic cavity6.40e-0834
orifice8.67e-0836
thoracic segment organ1.43e-0735
oral opening3.10e-0722
mammary gland4.82e-074
mammary bud4.82e-074
mammary ridge4.82e-074
mammary placode4.82e-074
thoracic segment of trunk8.92e-0752
respiratory system epithelium9.19e-0728
Disease
Ontology termp-valuen
carcinoma5.47e-26106
cell type cancer9.08e-17143
squamous cell carcinoma1.38e-1314
cancer6.51e-08235
disease of cellular proliferation1.93e-07239
disease of anatomical entity2.13e-0739


Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs



JASPAR motifs

Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}



ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data


(#promoters = Number of promoters in this coexpression cluster that have ChIP signal of the TF)

TF#promotersEnrichmentp-valueq-value
FOXA1#3169611.08141974938555.39600313513231e-072.51137776929627e-05
MXI1#460169.96157162875931.02262624227062e-064.30827196920133e-05
MYC#460965.22228187160944.92821127172503e-050.000854979164464603
POLR2A#543062.147453176558070.01019570676818780.0380799420363611
USF1#739166.361499277207961.50818327938273e-050.000357172683708511



Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data


This analysis result is provided for C0 - C305 clusters.